Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 67 |
| List of Tables | 59 | 9 |
| List of Figures | 68 | 1 |
| Introduction | 69 | 1 |
| Global Markets Direct Report Coverage | 69 | 1 |
| Prostate Cancer Overview | 70 | 1 |
| Therapeutics Development | 71 | 2 |
| Pipeline Products for Prostate Cancer Overview | 71 | 1 |
| Pipeline Products for Prostate Cancer Comparative Analysis | 72 | 1 |
| Prostate Cancer Therapeutics under Development by Companies | 73 | 22 |
| Prostate Cancer Therapeutics under Investigation by Universities/Institutes | 95 | 4 |
| Prostate Cancer Pipeline Products Glance | 99 | 4 |
| Late Stage Products | 99 | 1 |
| Clinical Stage Products | 100 | 1 |
| Early Stage Products | 101 | 1 |
| Unknown Stage Products | 102 | 1 |
| Prostate Cancer Products under Development by Companies | 103 | 30 |
| Prostate Cancer Products under Investigation by Universities/Institutes | 133 | 6 |
| Prostate Cancer Companies Involved in Therapeutics Development | 139 | 257 |
| 4SC AG | 139 | 1 |
| AB Science SA | 140 | 1 |
| AbbVie Inc. | 141 | 1 |
| Acino International AG | 142 | 1 |
| Actinium Pharmaceuticals, Inc. | 143 | 1 |
| Adamis Pharmaceuticals Corporation | 144 | 1 |
| ADC Therapeutics Sarl | 145 | 1 |
| Aduro BioTech, Inc. | 146 | 1 |
| Advanced Accelerator Applications S.A. | 147 | 1 |
| Advanced Cancer Therapeutics | 148 | 1 |
| Advantagene, Inc. | 149 | 1 |
| Advaxis, Inc. | 150 | 1 |
| Aeglea BioTherapeutics, Inc. | 151 | 1 |
| Aeolus Pharmaceuticals, Inc. | 152 | 1 |
| Aeterna Zentaris Inc. | 153 | 1 |
| Aileron Therapeutics, Inc. | 154 | 1 |
| Akshaya Bio Inc. | 155 | 1 |
| Alchemia Limited | 156 | 1 |
| Alethia Biotherapeutics Inc. | 157 | 1 |
| Almac Discovery Limited | 158 | 1 |
| Ambrx, Inc. | 159 | 1 |
| American Gene Technologies International Inc. | 160 | 1 |
| Amgen Inc. | 161 | 1 |
| Anavex Life Sciences Corp. | 162 | 1 |
| AndroScience Corporation | 163 | 1 |
| AnGes MG, Inc. | 164 | 1 |
| AntiCancer, Inc. | 165 | 1 |
| Antigen Express, Inc. | 166 | 1 |
| Antisense Therapeutics Limited | 167 | 1 |
| Apac Biotech Pvt Ltd | 168 | 1 |
| Apcure SAS | 169 | 1 |
| Aphios Corporation | 170 | 1 |
| APIM Therapeutics AS | 171 | 1 |
| Aptose Biosciences Inc. | 172 | 1 |
| Armour Therapeutics Inc. | 173 | 1 |
| Arno Therapeutics, Inc. | 174 | 1 |
| ArQule, Inc. | 175 | 1 |
| Arrien Pharmaceuticals, LLC | 176 | 1 |
| Arrowhead Pharmaceuticals, Inc. | 177 | 1 |
| Arvinas, Inc. | 178 | 1 |
| Asana BioSciences, LLC | 179 | 1 |
| Astellas Pharma Inc. | 180 | 1 |
| Asterias Biotherapeutics, Inc. | 181 | 1 |
| AstraZeneca Plc | 182 | 1 |
| ATLAB Pharma SAS | 183 | 1 |
| Avipep Pty Ltd | 184 | 1 |
| Azaya Therapeutics, Inc. | 185 | 1 |
| Bavarian Nordic A/S | 186 | 1 |
| Baxalta Incorporated | 187 | 1 |
| Bayer AG | 188 | 1 |
| Bexion Pharmaceuticals, LLC. | 189 | 1 |
| BHR Pharma, LLC | 190 | 1 |
| BIND Therapeutics, Inc. | 191 | 1 |
| Bio-Cancer Treatment International Limited | 192 | 1 |
| Bionature E.A. Ltd. | 193 | 1 |
| Biotest AG | 194 | 1 |
| Biscayne Pharmaceuticals, Inc. | 195 | 1 |
| Blirt S.A. | 196 | 1 |
| Boehringer Ingelheim GmbH | 197 | 1 |
| Bristol-Myers Squibb Company | 198 | 1 |
| Camurus AB | 199 | 1 |
| Can-Fite BioPharma Ltd. | 200 | 1 |
| CEL-SCI Corporation | 201 | 1 |
| Celgene Corporation | 202 | 1 |
| CellCentric Ltd | 203 | 1 |
| Cellceutix Corporation | 204 | 1 |
| Celldex Therapeutics, Inc. | 205 | 1 |
| Cellectar Biosciences, Inc. | 206 | 1 |
| Celprogen, Inc. | 207 | 1 |
| Chamaeleo Pharma NV | 208 | 1 |
| CohBar, Inc. | 209 | 1 |
| Colby Pharmaceutical Company | 210 | 1 |
| Corcept Therapeutics Incorporated | 211 | 1 |
| Corvus Pharmaceuticals, Inc. | 212 | 1 |
| Crescendo Biologics Limited | 213 | 1 |
| CureVac GmbH | 214 | 1 |
| CytoVac A/S | 215 | 1 |
| CZ BioMed Corp | 216 | 1 |
| Deciphera Pharmaceuticals, LLC | 217 | 1 |
| DEKK-TEC, Inc. | 218 | 1 |
| DexTech Medical AB | 219 | 1 |
| Diffusion Pharmaceuticals Inc. | 220 | 1 |
| Dongkook Pharmaceutical Co., Ltd. | 221 | 1 |
| DormaTarg, Inc. | 222 | 1 |
| Eisai Co., Ltd. | 223 | 1 |
| Eli Lilly and Company | 224 | 1 |
| Emergent BioSolutions Inc. | 225 | 1 |
| Enceladus Pharmaceuticals BV | 226 | 1 |
| Endo Pharmaceuticals Inc. | 227 | 1 |
| EndoCeutics, Inc. | 228 | 1 |
| Endocyte, Inc. | 229 | 1 |
| EntreChem, S.L. | 230 | 1 |
| Errant Gene Therapeutics, LLC | 231 | 1 |
| Esperance Pharmaceuticals, Inc. | 232 | 1 |
| ESSA Pharma Inc | 233 | 1 |
| Eureka Therapeutics, Inc. | 234 | 1 |
| Evgen Pharma Plc | 235 | 1 |
| Exonate Limited | 236 | 1 |
| F. Hoffmann-La Roche Ltd. | 237 | 1 |
| Ferring International Center S.A. | 238 | 1 |
| Foresee Pharmaceuticals, LLC | 239 | 1 |
| Fountain Biopharma Inc. | 240 | 1 |
| Fujifilm Corporation | 241 | 1 |
| G1 Therapeutics, Inc. | 242 | 1 |
| Galectin Therapeutics, Inc. | 243 | 1 |
| Genelux Corporation | 244 | 1 |
| Genentech, Inc. | 245 | 1 |
| Genmab A/S | 246 | 1 |
| GenSpera, Inc. | 247 | 1 |
| Gilead Sciences, Inc. | 248 | 1 |
| Glactone Pharma AB | 249 | 1 |
| GlaxoSmithKline Plc | 250 | 1 |
| GlycoMimetics, Inc. | 251 | 1 |
| GP Pharm, S.A. | 252 | 1 |
| GTx, Inc. | 253 | 1 |
| Hadasit Medical Research Services &Development Ltd | 254 | 1 |
| Hybrigenics S.A. | 255 | 1 |
| IC-MedTech, Inc. | 256 | 1 |
| Ideaya Biosciences, Inc. | 257 | 1 |
| IGF Oncology, LLC. | 258 | 1 |
| Ignyta, Inc. | 259 | 1 |
| Immune Pharmaceuticals Inc. | 260 | 1 |
| Immuneed AB | 261 | 1 |
| Immunocore Limited | 262 | 1 |
| ImmunoFrontier, Inc. | 263 | 1 |
| Immunomedics, Inc. | 264 | 1 |
| Immupharma Plc | 265 | 1 |
| Incanthera Ltd. | 266 | 1 |
| Incuron, LLC | 267 | 1 |
| Innate Immunotherapeutics Ltd | 268 | 1 |
| Inovio Pharmaceuticals, Inc. | 269 | 1 |
| Io Therapeutics, Inc. | 270 | 1 |
| Ipsen S.A. | 271 | 1 |
| Jiangsu Hengrui Medicine Co., Ltd. | 272 | 1 |
| Johnson &Johnson | 273 | 1 |
| Jyant Technologies, Inc. | 274 | 1 |
| KaloBios Pharmaceuticals, Inc. | 275 | 1 |
| Karyopharm Therapeutics, Inc. | 276 | 1 |
| Kite Pharma, Inc. | 277 | 1 |
| Komipharm International Co., Ltd. | 278 | 1 |
| Kura Oncology, Inc. | 279 | 1 |
| Kyowa Hakko Kirin Co., Ltd. | 280 | 1 |
| Lidds AB | 281 | 1 |
| Luye Pharma Group Ltd. | 282 | 1 |
| MacroGenics, Inc. | 283 | 1 |
| Mallinckrodt Plc | 284 | 1 |
| MaxiVAX SA | 285 | 1 |
| Meabco A/S | 286 | 1 |
| Mebiopharm Co., Ltd. | 287 | 1 |
| MediaPharma s.r.l. | 288 | 1 |
| Medicenna Therapeutics, Inc. | 289 | 1 |
| MediGene AG | 290 | 1 |
| MedImmune, LLC | 291 | 1 |
| Mediolanum farmaceutici S.p.A. | 292 | 1 |
| Medivation, Inc. | 293 | 1 |
| MEI Pharma, Inc. | 294 | 1 |
| Merck &Co., Inc. | 295 | 1 |
| Merck KGaA | 296 | 1 |
| Millennium Pharmaceuticals, Inc. | 297 | 1 |
| Minerva Biotechnologies Corporation | 298 | 1 |
| Mirna Therapeutics, Inc. | 299 | 1 |
| Mithra Pharmaceuticals S.A. | 300 | 1 |
| MolMed S.p.A. | 301 | 1 |
| Monopar Therapeutics LLC | 302 | 1 |
| Morphotek, Inc. | 303 | 1 |
| NewLink Genetics Corporation | 304 | 1 |
| NormOxys, Inc. | 305 | 1 |
| Novartis AG | 306 | 1 |
| Novogen Limited | 307 | 1 |
| Nymox Pharmaceutical Corporation | 308 | 1 |
| Oasmia Pharmaceutical AB | 309 | 1 |
| Omeros Corporation | 310 | 1 |
| Omnitura Therapeutics Inc. | 311 | 1 |
| OncBioMune Pharmaceuticals Inc. | 312 | 1 |
| Oncodrone BV | 313 | 1 |
| Oncogenex Pharmaceuticals, Inc. | 314 | 1 |
| Oncolix, Inc. | 315 | 1 |
| Oncolytics Biotech Inc. | 316 | 1 |
| OncoMax | 317 | 1 |
| OncoNOx ApS | 318 | 1 |
| OncoTartis, Inc. | 319 | 1 |
| Oncovir, Inc. | 320 | 1 |
| OncoVista Innovative Therapies, Inc. | 321 | 1 |
| ORCA Therapeutics B.V. | 322 | 1 |
| Oribase Pharma | 323 | 1 |
| Orion Oyj | 324 | 1 |
| Orphagen Pharmaceuticals, Inc. | 325 | 1 |
| Otsuka Holdings Co., Ltd. | 326 | 1 |
| OXiGENE, Inc. | 327 | 1 |
| Panacela Labs, Inc. | 328 | 1 |
| PDS Biotechnology Corporation | 329 | 1 |
| Peptron, Inc. | 330 | 1 |
| Pfizer Inc. | 331 | 1 |
| Pharmedartis GmbH | 332 | 1 |
| Pharmicell Co., Ltd. | 333 | 1 |
| Pharminox Limited | 334 | 1 |
| Polaris Pharmaceuticals, Inc. | 335 | 1 |
| Polyplus-Transfection SA | 336 | 1 |
| Prima BioMed Ltd. | 337 | 1 |
| Princeton University | 338 | 1 |
| Progenics Pharmaceuticals, Inc. | 339 | 1 |
| Provectus Biopharmaceuticals, Inc. | 340 | 1 |
| Provenance Biopharmaceuticals Corp. | 341 | 1 |
| PSites Pharma GmbH | 342 | 1 |
| Qu Biologics Inc. | 343 | 1 |
| Quest PharmaTech Inc. | 344 | 1 |
| RedHill Biopharma Ltd. | 345 | 1 |
| Rexahn Pharmaceuticals, Inc. | 346 | 1 |
| Rigontec GmbH | 347 | 1 |
| Sanofi | 348 | 1 |
| Sareum Holdings Plc | 349 | 1 |
| SEEK Group | 350 | 1 |
| Serometrix, LLC | 351 | 1 |
| Shenogen Pharma Group Ltd. | 352 | 1 |
| Snowdon Inc. | 353 | 1 |
| Sophiris Bio, Inc. | 354 | 1 |
| Soricimed Biopharma Inc. | 355 | 1 |
| Sorrento Therapeutics, Inc. | 356 | 1 |
| Sotio a.s. | 357 | 1 |
| Stemline Therapeutics, Inc. | 358 | 1 |
| Sunesis Pharmaceuticals, Inc. | 359 | 1 |
| Supratek Pharma Inc. | 360 | 1 |
| Synta Pharmaceuticals Corp. | 361 | 1 |
| TaiGen Biotechnology Co., Ltd. | 362 | 1 |
| Taiho Pharmaceutical Co., Ltd. | 363 | 1 |
| Taiwan Liposome Company, Ltd. | 364 | 1 |
| Takeda Pharmaceutical Company Limited | 365 | 1 |
| Takis S.r.l. | 366 | 1 |
| Targovax AS | 367 | 1 |
| Tesaro, Inc. | 368 | 1 |
| Teva Pharmaceutical Industries Ltd. | 369 | 1 |